Tyler TX 癌症（所有类型）临床试验
7项针对 癌症（所有类型）的研究正在 Tyler及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
招募中3 期
- Texas Oncology - Northeast Texas, Tyler
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- Texas Oncology - Northeast Texas /ID# 280642, Tyler
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- University of Texas at Tyler, Tyler
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
招募中1/2 期
- The University of Texas Health Science Center at Tyler, Tyler
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Texas Oncology - Northeast Texas /ID# 268877, Tyler
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
招募中1 期
- GSK Investigational Site, Tyler
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
招募中2 期
- Texas Oncology - Tyler, Tyler
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY110 项研究
- Boston, MA86 项研究
- Los Angeles, CA73 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Durham, NC58 项研究
- Washington, DC58 项研究
- Chicago, IL51 项研究
- Seattle, WA49 项研究
- Atlanta, GA49 项研究
- Arlington, VA48 项研究
Tyler的其他研究
- 非小细胞肺癌20 项研究
- 克罗恩病16 项研究
- 溃疡性结肠炎14 项研究
- 结直肠癌8 项研究
- 心力衰竭8 项研究
- 卵巢癌7 项研究
- 子宫内膜癌6 项研究
- 头颈鳞状细胞癌6 项研究
- 乳腺癌6 项研究
- 转移性癌症5 项研究
- 炎症性肠病5 项研究
- 慢性淋巴细胞白血病5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。